Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activity
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activity
Authors
Keywords
-
Journal
HUMAN MOLECULAR GENETICS
Volume 23, Issue 1, Pages 268-278
Publisher
Oxford University Press (OUP)
Online
2013-08-29
DOI
10.1093/hmg/ddt417
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants
- (2013) J K Hicks et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Relevance of “Missing Heritability ” in Pharmacogenomics
- (2012) W Sadee CLINICAL PHARMACOLOGY & THERAPEUTICS
- The long-range interaction landscape of gene promoters
- (2012) Amartya Sanyal et al. NATURE
- Cholesteryl Ester Transfer Protein (CETP) Polymorphisms Affect mRNA Splicing, HDL Levels, and Sex-Dependent Cardiovascular Risk
- (2012) Audrey C. Papp et al. PLoS One
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy
- (2011) S A Scott et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype
- (2011) K R Crews et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity
- (2011) Danxin Wang et al. Pharmacogenetics and Genomics
- CYP2D6,SULT1A1andUGT2B17copy number variation: quantitative detection by multiplex PCR
- (2011) Andrea Gaedigk et al. PHARMACOGENOMICS
- Assessment of Activity Levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 Genes by Population Pharmacokinetics of Dextromethorphan
- (2010) K Abduljalil et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Nicotinic α5 receptor subunit mRNA expression is associated with distant 5′ upstream polymorphisms
- (2010) Ryan M Smith et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver
- (2010) X. Yang et al. GENOME RESEARCH
- Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs
- (2010) D Wang et al. PHARMACOGENOMICS JOURNAL
- Identification of Novel CYP2D7-2D6 Hybrids: Non-Functional and Functional Variants
- (2010) Andrea Gaedigk et al. Frontiers in Pharmacology
- CYP2D7–2D6hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction
- (2009) Andrea Gaedigk et al. PHARMACOGENOMICS
- Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement
- (2008) D. Wang et al. BLOOD
- Functional Characterization of 17 CYP2D6 Allelic Variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57)
- (2008) K. Sakuyama et al. DRUG METABOLISM AND DISPOSITION
- Mapping the Genetic Architecture of Gene Expression in Human Liver
- (2008) Eric E Schadt et al. PLOS BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started